Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Isaka

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Antibiotics|March 28, 2001
Bioxanthracenes from the insect pathogenic fungus. Cordyceps pseudomilitaris BCC 1620. I. Taxonomy, fermentation, isolation and antimalarial activityA Jaturapat, M Isaka, N L Hywel-Jones, et al.
Oral Microbiology and Immunology|October 24, 2007
Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunitY Takahashi, H Kumada, N Hamada, et al.
Diabetes Research (Edinburgh, Scotland)|January 1, 1993
Hemodynamic effects of lipo-PGE1 on peripheral artery in patients with diabetic neuropathy: evaluated by two-dimensional color Doppler echographyY Okuda, M Mizutani, M Ogawa, et al.
Nucleic Acids Research|January 24, 1986
Revised assignment for the Bacillus subtilis spo0F gene and its homology with spo0A and with two Escherichia coli genesH Yoshikawa, J Kazami, S Yamashita, et al.
Vaccine|November 5, 1999
Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvantM Isaka, Y Yasuda, S Kozuka, et al.
Vaccine|March 15, 2000
Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvantN Goto, J Maeyama, Y Yasuda, et al.
Life Sciences|May 19, 1998
Alpha1-adrenoceptor subtypes and two receptor systems in vascular tissuesI Muramatsu, S Murata, M Isaka, et al.
Vaccine|March 4, 2000
Efficient extracellular production of recombinant Escherichia coli heat-labile enterotoxin B subunit by using the expression/secretion system of Bacillus brevis and its mucosal immunoadjuvanticityS Kozuka, Y Yasuda, M Isaka, et al.
Bioorganic & Medicinal Chemistry|June 3, 1999
Cyclopropenone-containing cysteine proteinase inhibitors. Synthesis and enzyme inhibitory activitiesR Ando, T Sakaki, Y Morinaka, et al.
Journal of Diabetes and Its Complications|September 1, 1996
Long-term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes mellitusY Okuda, M Mizutani, M Ogawa, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Antibiotics|March 28, 2001
Bioxanthracenes from the insect pathogenic fungus. Cordyceps pseudomilitaris BCC 1620. I. Taxonomy, fermentation, isolation and antimalarial activityA Jaturapat, M Isaka, N L Hywel-Jones, et al.
Oral Microbiology and Immunology|October 24, 2007
Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunitY Takahashi, H Kumada, N Hamada, et al.
Diabetes Research (Edinburgh, Scotland)|January 1, 1993
Hemodynamic effects of lipo-PGE1 on peripheral artery in patients with diabetic neuropathy: evaluated by two-dimensional color Doppler echographyY Okuda, M Mizutani, M Ogawa, et al.
Nucleic Acids Research|January 24, 1986
Revised assignment for the Bacillus subtilis spo0F gene and its homology with spo0A and with two Escherichia coli genesH Yoshikawa, J Kazami, S Yamashita, et al.
Vaccine|November 5, 1999
Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvantM Isaka, Y Yasuda, S Kozuka, et al.
Vaccine|March 15, 2000
Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvantN Goto, J Maeyama, Y Yasuda, et al.
Life Sciences|May 19, 1998
Alpha1-adrenoceptor subtypes and two receptor systems in vascular tissuesI Muramatsu, S Murata, M Isaka, et al.
Vaccine|March 4, 2000
Efficient extracellular production of recombinant Escherichia coli heat-labile enterotoxin B subunit by using the expression/secretion system of Bacillus brevis and its mucosal immunoadjuvanticityS Kozuka, Y Yasuda, M Isaka, et al.
Bioorganic & Medicinal Chemistry|June 3, 1999
Cyclopropenone-containing cysteine proteinase inhibitors. Synthesis and enzyme inhibitory activitiesR Ando, T Sakaki, Y Morinaka, et al.
Journal of Diabetes and Its Complications|September 1, 1996
Long-term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes mellitusY Okuda, M Mizutani, M Ogawa, et al.
Pageof 6